Navigation Links
Onyx Pharmaceuticals Provides Status Update on Carfilzomib
Date:10/7/2010

EMERYVILLE, Calif., Oct. 7 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will delay its New Drug Application (NDA) filing for carfilzomib based on a recent meeting with the Chemistry, Manufacturing and Controls (CMC) review division of the U.S. Food and Drug Administration (FDA).  The FDA has requested additional CMC information related to commercial-scale manufacturing of carfilzomib.  Onyx had previously anticipated filing an NDA by the end of 2010 for accelerated approval of carfilzomib and now expects that its NDA filing for accelerated approval could occur as early as mid-year 2011.

The clinical profile of carfilzomib has not changed, and no new safety signals have been observed. The Phase 3 trials are on schedule and actively enrolling patients, and this change is not expected to impact any of the carfilzomib trials or other development plans.

In preparation for commercial-scale production, the company made manufacturing process enhancements in the production of carfilzomib, which are customary when migrating from clinical to commercial-scale manufacturing.  In a recently completed manufacturing-scale run, the company observed minor variations that are believed to be primarily related to equipment temperature variances.  In response to FDA's request, Onyx is providing the agency with additional CMC information.  Onyx has additional data and is generating more information to share as part of the ongoing dialogue with the CMC review division in preparation for an NDA filing.

"We are confident in the clinical and preclinical data package supporting the carfilzomib NDA and in our manufacturing strategy," said N. Anthony Coles, M.D., president and chief executive officer of Onyx. "We believe that by providing this supportive data, we will strengthen our NDA package, thus enabling us to bring carfilzom
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... -- AARP Foundation today announced it has established a ... from the severe cold weather that has gripped much ... to helping those in need; so to support these ... dollar-for-dollar contributions up to $250,000, which could mean up ... administered through AARP Foundation. (Logo: ...
(Date:1/15/2014)... Jan. 15, 2014  Celsion Corporation (the "Company") (NASDAQ: ... has received commitments from institutional investors to purchase ... Company,s common stock in an at-the-market registered direct ... The Company entered into definitive purchase ... Company agreed to sell an aggregate of 3,603,603 ...
(Date:1/15/2014)... January 15, 2014 Shire plc (LSE: ... waived the Office of Fair Trading (OFT) approval condition to ... of ViroPharma Incorporated (NASDAQ: VPHM).   As a ... on OFT approval, and Shire expects to complete the tender ... time, subject to the satisfaction of all of the remaining ...
Breaking Medicine Technology:AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3
... 60 Plus Association today sent a letter of gratitude ... contacted the Federal Trade Commission (FTC) with concerns over ... Scripts, Inc. and Medco Health Solutions. The organization made ... of their 7.1 million supporters to defend patient choice, ...
... , a leader in pharmacy automation, celebrates its 10th ... is dedicated to providing enterprise-wide medication management across the ... and improved patient safety. Talyst has more ... products. The company partners with pharmacies to create the ...
Cached Medicine Technology:60 Plus Association Applauds Opposition to PBM Merger 2
(Date:4/14/2014)... orphaned by HIV/AIDS in South Africa may provide insight ... behavior issues in other areas of the world, which ... that could lead to successful interventions. , A ... United Nations mentions that due to the HIV/AIDS pandemic, ... African, children are at an increased risk for mental ...
(Date:4/14/2014)... A new study shows that moderate to severe ... risk of stroke, cancer and death. , Results of ... to severe obstructive sleep apnea were four times more ... times more likely to have a stroke (HR = ... (HR = 3.4), and 2.5 times more likely to ...
(Date:4/14/2014)... Dallas study involving serious youth offenders, the answer to one ... seven years: "How long do you think you,ll live?", According ... offending over time., Author Dr. Alex Piquero said the study ... of them offend at very high rates and commit more ... much later in life offend much less., "In a lot ...
(Date:4/14/2014)... with symptoms increasing dramatically during some of the most important ... has found. , Depressive symptoms increased on average by 68 ... young men, who were around 25 years old when they ... their children. The results of the study were published April ... is the first to identify when young fathers are at ...
(Date:4/14/2014)... Lower weight babies and babies who aren,t breastfed ... risk of developing chronic inflammation and related health ... study. , "There were good reasons to hypothesize ... inflammation in adulthood," says Thomas McDade (Northwestern University), ... in the Child & Brain Development program. "It ...
Breaking Medicine News(10 mins):Health News:Researchers identify children with emotional behavior difficulties 2Health News:Researchers identify children with emotional behavior difficulties 3Health News:Study links severe sleep apnea to increased risk of stroke, cancer and death 2Health News:UT Dallas study: Youth who fail to envision future commit more crimes 2Health News:Young dads at high risk of depression, too 2Health News:Low birth weight, less breastfeeding create later health risks 2
... stance on bisphenol A (BPA) and said that exposure to ... Previously, the agency,s stance was the chemical posed no risk ... stance. Today, FDA officials declared that more research was needed ... vom Saal, a University of Missouri scientist, says that this ...
... ... ... -- During Glaucoma Awareness Month, Summit Medical Group wants to help people understand its risks, ... Because there often are no symptoms in its early stages, many people do not know ...
... ... of North America (CASANA), through its Childhood Apraxia of Speech (CAS) ... Dale, Ph.D., University of New Mexico and Deborah Hayden, MA, CCC-SLP, ... Award. An external expert committee along with two parents ...
... ... surgeons worldwide and hindsight could soon be 20/10. He believes that vision beyond 20/20 is possible ... their patients. , ... -- 20/20 vision has been the hallmark of perfect vision. That Bar is about to be ...
... , INDIANAPOLIS , Jan. 19 ... has announced the completion of its $8 million ... Menlo Park, California .  The funding will allow Orbis Education ... in turn, help alleviate the nation,s wide-spread nursing shortages. , ...
... Dr. David Schor, ... treatments that are available at Imagine Advanced Dental Arts, his Lawrenceville, New Jersey cosmetic ... form, the new website provides patients with an interactive look at all that his practice ... Lawrenceville, ...
Cached Medicine News:Health News:FDA BPA decision is a step forward, but more needs to happen, says MU expert 2Health News:January is Glaucoma Awareness Month 2Health News:Childhood Apraxia of Speech Association of North America Awards Treatment Research Grant to University of New Mexico/PROMPT Institute 2Health News:Childhood Apraxia of Speech Association of North America Awards Treatment Research Grant to University of New Mexico/PROMPT Institute 3Health News:20/10 Vision in the Year 2010: Is "HD Vision" Beyond 20/20 a Reality? 2Health News:20/10 Vision in the Year 2010: Is "HD Vision" Beyond 20/20 a Reality? 3Health News:Orbis Education Secures $8.0 Million in Funding for Expanding Online Nursing Education Platform 2Health News:Orbis Education Secures $8.0 Million in Funding for Expanding Online Nursing Education Platform 3Health News:Orbis Education Secures $8.0 Million in Funding for Expanding Online Nursing Education Platform 4Health News:A Top Cosmetic Dentistry Practice in Central New Jersey Announces Launch of New, State-of-the-Art Website 2Health News:A Top Cosmetic Dentistry Practice in Central New Jersey Announces Launch of New, State-of-the-Art Website 3Health News:A Top Cosmetic Dentistry Practice in Central New Jersey Announces Launch of New, State-of-the-Art Website 4
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: